Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
about
HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsThe envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible speciesThe human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradationHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchViral Membrane Channels: Role and Function in the Virus Life CycleSequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathwayNef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach.Bacteria-based analysis of HIV-1 Vpu channel activity.The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs.Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay.Down-regulation of cell surface CXCR4 by HIV-1Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein.Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivityNef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.HIV-1 Vpu - an ion channel in search of a job.Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1.
P2860
Q24619066-D95FA1DB-2D79-49CF-AC2B-E9A40C1C9FBEQ24670601-12B76A7A-8D16-4156-897A-4FD3285ACC4BQ24675131-06232B77-7A08-48D9-B29C-DF0F814CB580Q24676509-48BD3009-A116-4E30-A2A5-C7FCDCAEAA48Q26746070-31A59511-A8AF-47D7-92C6-5839C33E517DQ27000898-5E43A4A3-3326-4155-A57B-61488C628E86Q30452649-790ACA8F-8C9B-4DA5-9B49-A281C5E93795Q33640055-0CD19F80-C5DB-43E4-B2AF-A63B7F685A61Q33782459-6499491F-5EC4-4BFC-A74E-990DF0C12542Q34186134-79D5E039-ABC8-4A4A-BAFF-388D5C83E41CQ35028829-33AD2973-C5B6-459F-9B70-5A6013907D6BQ35291655-B2D0D908-504E-446C-B876-03711ACC9614Q35854362-2E98E812-8A9D-49EE-B8B5-EBE22FD19B09Q35854386-FE13DFE2-2343-4568-8CB5-95B55706597EQ35857341-CFEE8789-0641-4FA3-9D06-AF33429003D5Q35860996-A222AE93-F6DC-4C50-B2F3-47664C7C053DQ35861652-449E1C49-F694-44A5-A6AA-6820210673BAQ35873115-F51F5FD1-B420-4C17-9D26-D8776801DB00Q36288363-08828062-8F3C-43A4-B4C4-A1112154625AQ36470083-48B07115-61C5-4AEA-917B-CFE72C7E23F6Q36627720-4840CF78-0EB4-4AF1-AA9E-127E4EC9B877Q36649813-D97FBDC8-1717-44F6-8D4A-D2E63BA75999Q36651371-E08F1471-60BD-404E-AFAB-9DE0374E9C5FQ36652213-2A427482-3E76-4103-B078-DA89616E8E24Q36669879-4F8D0C84-1A22-40FD-930E-A262D3B591F6Q36685444-4200731E-58D6-43D1-AEF2-57DC26DEE143Q36687143-A24DC0E2-F3B2-4CD4-8A04-A5BF7E3E296EQ36687162-C6E5D335-5050-4DB5-9080-70EA5F35CB2FQ37072116-026AD56E-7741-48DD-A860-EB21BB5E54A9Q37384691-4AD686B2-3B0A-46BC-9A4D-8E1F13D4ADFDQ39879855-BA91D46F-4E6B-4ACC-824A-87110B2F039E
P2860
Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Inhibition of gp160 and CD4 ma ...... immunodeficiency virus type 1.
@en
type
label
Inhibition of gp160 and CD4 ma ...... immunodeficiency virus type 1.
@en
prefLabel
Inhibition of gp160 and CD4 ma ...... immunodeficiency virus type 1.
@en
P2860
P1433
P1476
Inhibition of gp160 and CD4 ma ...... immunodeficiency virus type 1
@en
P2093
Boulerice F
Wainberg MA
P2860
P304
P407
P50
P577
1991-12-01T00:00:00Z